Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 42.08B | 41.10B | 51.02B | 32.85B | 27.82B |
Gross Profit | 4.37B | 4.79B | 4.86B | 3.96B | 3.85B |
EBITDA | 1.79B | 2.08B | 2.22B | 1.38B | 1.52B |
Net Income | 382.00M | 626.00M | 694.00M | 367.00M | 446.00M |
Balance Sheet | |||||
Total Assets | 47.74B | 44.85B | 45.69B | 44.65B | 43.67B |
Cash, Cash Equivalents and Short-Term Investments | 5.32B | 5.19B | 5.89B | 5.72B | 6.30B |
Total Debt | 18.01B | 17.19B | 17.23B | 18.33B | 17.37B |
Total Liabilities | 31.64B | 28.64B | 29.90B | 29.51B | 28.60B |
Stockholders Equity | 15.66B | 15.78B | 15.31B | 14.68B | 14.58B |
Cash Flow | |||||
Free Cash Flow | -97.00M | -185.00M | 1.68B | -1.87B | -1.20B |
Operating Cash Flow | 906.00M | 503.00M | 2.33B | 398.00M | 711.00M |
Investing Cash Flow | -1.03B | -741.00M | -613.00M | -1.60B | -1.52B |
Financing Cash Flow | 235.00M | -472.00M | -1.56B | 622.00M | 627.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥71.65B | 8.39 | 2.71% | 41.28% | -11.01% | ||
74 Outperform | ¥58.94B | 11.90 | 3.45% | 7.61% | -11.92% | ||
73 Outperform | ¥7.68B | 5.84 | 4.75% | -0.11% | -19.84% | ||
72 Outperform | ¥5.50B | 14.40 | 5.52% | 2.36% | -38.98% | ||
69 Neutral | ¥49.54B | 8.22 | 3.22% | 5.73% | 27.30% | ||
64 Neutral | ¥11.88B | 18.94 | 1.85% | 8.01% | 28.74% | ||
58 Neutral | HK$14.16B | 4.51 | -3.01% | 6.93% | 3.67% | -54.16% |